Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

HFRX Global Hedge Fund Index gains +1.72% in January

Friday, February 03, 2012
Opalesque Industry Update - Global equities posted strong gains to begin 2012 with leadership from Technology and Financials, as US economic data showed signs of improvement and sentiment improved with regard to clarity on resolution of the European sovereign debt crisis. The US Dollar declined against the Euro and Yen, while the US treasury curved steepened as longer dated yields rose. Credit tightened throughout the month while commodity metals rallied, despite a sharp decline in Natural Gas.

Hedge Funds posted their strongest gains since 2010, with the HFRX Global Hedge Fund Index gaining +1.72% for the month, while the HFRX Market Directional Index gained +1.88%.

The HFRX Event Driven Index posted a gain of +2.80%, its strongest performance since May '07, with positive contributions across all Event Driven strategies, concentrated in Distressed and Activist strategies. Corporate credit and M&A deal spreads tightened, despite the termination of the NYSE/Deutsche Borse transaction. The HFRX Distressed Index posted a gain of +3.10%, its strongest performance in 22 months, while the HFRX Special Situations Index posted a gain of +2.18% for the month. M&A activity continued with deals in the pharmaceutical and technology sectors, with the HFRX Merger Arbitrage Index gaining +0.51%.

The HFRX Equity Hedge Index gained +2.07%, the largest gain since December 2010, with gains concentrated in Energy/Basic Material, Financials and Technology/Healthcare sectors. Managers benefitted from improving conditions and reduced volatility in the equity markets; Fundamental Growth strategies posted gains from exposure to US small cap, Latin America and Asia ex-China, while Fundamental Value managers benefited from European positioning while Japanese exposure detracted. The HFRX Fundamental Growth Index and the HFRX Fundamental Value Index posted a gain of +2.11% and +0.96%, respectively, while Market neutral strategies had positive performance, with the HFRX Equity Market Neutral Index gaining +0.41%.

The HFRX Relative Value Arbitrage Index posted a gain of +1.72% for January, with gains across all Relative Value strategies. Tightening of yields spreads and improved equity markets favored convertible strategies, with the HFRX Convertible Arbitrage Index and the HFRX RVA Multi-Strategy Index gaining +2.13% and +1.59%, respectively. Fixed Income-Corporate strategies were also positive for the period, while Yield Alternative/Energy Infrastructure experienced declines.

The HFRX Macro/CTA Index gained +0.09% for the month, from positive contribution from fixed-income and agricultural commodities exposure, partially offset by declines in systematic diversified funds. Short-term systematic strategies declined while medium-term funds posted gains, with HFRX Systematic Diversified CTA Index posted a decline of -1.00% for the month. Discretionary global rates currency managers posted gains, while commodity strategies had mixed performance.

Comments reference performance figures as posted on February 3, 2012

(press release)

Full performance table here.

BG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its